/DMIIU
DMIIU Stock - Drugs Made In America Acquisition II Corp. Unit
Financial Services|Asset ManagementNASDAQ
$9.99-0.10%
$0.01 (-0.10%) • Dec 19
63
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.49
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.80
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $10.99
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for DMIIU
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$9.89 – $10.09
TARGET (TP)$11.49
STOP LOSS$9.19
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.00
52W High$10.06
52W Low$9.94
Avg VolumeN/A
Income Statement (Fiscal Year)
Loading financial data...
Company Overview
A SPAC (blank check company) incorporated in the Cayman Islands to pursue a business combination. The company aims to focus on pharmaceutical / drug sector targets to reduce U.S. reliance on global drug manufacturing. Each unit consists of one ordinary share and one right to receive one-tenth of a share upon completion of a qualifying business combination.
Loading analyst ratings...
Earnings History & Surprises
DMIIULoading earnings data...
Frequently Asked Questions about DMIIU
What is DMIIU's current stock price?
Drugs Made In America Acquisition II Corp. Unit (DMIIU) is currently trading at $9.99 per share. The stock has moved -0.10% today.
What is the analyst price target for DMIIU?
No analyst price targets are currently available for this stock.
What sector is Drugs Made In America Acquisition II Corp. Unit in?
Drugs Made In America Acquisition II Corp. Unit operates in the Financial Services sector, specifically within the Asset Management industry. The company is traded on the NASDAQ exchange.
What is DMIIU's market cap?
Drugs Made In America Acquisition II Corp. Unit has a market capitalization of $0.63 billion, making it a small-cap company.
Does DMIIU pay dividends?
No, Drugs Made In America Acquisition II Corp. Unit does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorEIC
Eagle Point Income Company Inc.
$11.37
Mkt Cap: $0.3B
GAIN
Gladstone Investment Corporation
$13.88
Mkt Cap: $0.5B
GAM
General American Investors Company, Inc.
$58.51
Mkt Cap: $1.4B
MSIF
MSC Income Fund, Inc.
$13.21
Mkt Cap: $0.6B
NCDL
Nuveen Churchill Direct Lending Corp.
$14.07
Mkt Cap: $0.7B
NEWT
NewtekOne, Inc.
$12.23
Mkt Cap: $0.3B
OCCI
OFS Credit Company, Inc.
$4.75
Mkt Cap: $0.1B
Explore stocks similar to DMIIU for comparison